Blogopmaak
The gene list - eligible genes and diseases
The DCRT has compiled a list of genes and diseases that we consider eligible for RNA therapy. This is by no means a comprehensive list, but a starting point for clinicians and researchers to get an idea what conditions we can target with personalized antisense oligonucleotides.
You can find the list following the link below:
DCRT gene list
posted on Mar 30, 2022
Two new DCRT papers have been published online
Team DCRT went for its annual outing to Leiden's escape rooms
N=1 Collaborative is looking for communication trainees
PhD Position in treatment-response fluid biomarkers for ASO treatments
Short report of the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
DCRT travel grants awarded to 3 PhD students
Dr Marlen Lauffer, a senior researcher at the Dutch Center for RNA Therapeutics, was invited to give a talk at the Genomics England research summit in London on the 9th of July. She presented DCRT's work on the identification of genes and diseases and guidelines for patient selection.
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam